Clinical Trial Update: A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PD-1 inhibitor combined with ICE chemotherapy for relapsed/refractory Gray Zone Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gray Zone Lymphoma
• Relapse Recurrence

Drugs mentioned

• ICE
• PD-1 inhibitor

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Gray Zone Lymphoma, Relapse/Recurrence | Phase 2 | Status: UNKNOWN